Search Results - "Mann, Tara K"

A School-Based SARS-CoV-2 Testing Program: Testing Uptake and Quarantine Length After In-School Exposures by Boutzoukas, Angelique E, Zimmerman, Kanecia O, Mann, Tara K, Moorthy, Ganga S, Blakemore, Ashley, McGann, Kathleen A, Smith, Michael J, Nutting, Boen, Kerley, Karen, Brookhart, M Alan, Edwards, Laura, Rak, Zsolt, Benjamin, Daniel K, Kalu, Ibukunoluwa C

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related quarantines, which are required after close contact with infected individuals, have…”
Get full text

Test-to-Stay After SARS-CoV-2 Exposure: A Mitigation Strategy for Optionally Masked K-12 Schools by Campbell, Melissa M, Benjamin, Daniel K, Mann, Tara K, Fist, Alex, Blakemore, Ashley, Diaz, Kylee S, Kim, Hwasoon, Edwards, Laura J, Rak, Zsolt, Brookhart, M Alan, Moore, Zack, Tilson, Elizabeth Cuervo, Kalu, Ibukun, Boutzoukas, Angelique E, Moorthy, Ganga S, Uthappa, Diya, Scott, Zeni, Weber, David J, Shane, Andi L, Bryant, Kristina A, Zimmerman, Kanecia O

“…We evaluated the impact of a test-to-stay (TTS) program on within-school transmission and missed school days in optionally masked kindergarten through 12th…”
Get full text

Assessing Depressive Symptoms in Patients With Cancer Treated With Interleukin-2: A Comparison of 2 Measures by McClintock, Shawn M., Dail, Robin B., Howe-Martin, Laura S., Mann, Tara K., Bailey, Donald E.

“…High-dose interleukin-2 is a therapy available for individuals with renal cell carcinoma; however, it can produce adverse effects, specifically depressive…”
Get full text

Masking Adherence in K-12 Schools and SARS-CoV-2 Secondary Transmission by Moorthy, Ganga S, Mann, Tara K, Boutzoukas, Angelique E, Blakemore, Ashley, Brookhart, M Alan, Edwards, Laura, Jackman, Jennifer G, Panayotti, Gabriela M Maradiaga, Warren, Todd, Pendleton, Joanna, Garcés, Andrew Willis, Corneli, Amy, Weber, David J, Kalu, Ibukunoluwa C, Benjamin, Daniel K, Zimmerman, Kanecia O

“…Masking is an essential coronavirus 2019 mitigation tool assisting in the safe return of kindergarten through 12th grade children and staff to in-person…”
Get full text

Test‐to‐Stay in Kindergarten Through 12th Grade Schools After Household Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 by Scott, Zeni, Uthappa, Diya M., Mann, Tara K., Kim, Hwasoon, Brookhart, M. A., Edwards, Laura, Rak, Zsolt, Benjamin, Daniel K., Zimmerman, Kanecia O.

“…ABSTRACT BACKGROUND Test‐to‐stay (TTS) is a strategy to limit school exclusion following an exposure to severe acute respiratory syndrome coronavirus 2…”
Get full text

Common Data Element Collection in Underserved School Communities: Challenges and Recommendations by Uthappa, Diya M, Mann, Tara K, Goldman, Jennifer L, Schuster, Jennifer E, Newland, Jason G, Anderson, William B, Dozier, Ann, Inkelas, Moira, Foxe, John J, Gwynn, Lisa, Gurnett, Christina A, McDaniels-Davidson, Corinne, Walsh, Tyler, Watterson, Tremayne, Holden-Wiltse, Jeanne, Potts, Jessie M, D'Agostino, Emily M, Zandi, Karen, Corbett, Anthony, Spallina, Samantha, DeMuri, Gregory P, Wu, Yelena P, Pulgaron, Elizabeth R, Kiene, Susan M, Oren, Eyal, Allison-Burbank, Joshuaa D, Okihiro, May, Lee, Rebecca E, Johnson, Sara B, Stump, Tammy K, Coller, Ryan J, Mast, Dana Keener, Haroz, Emily E, Kemp, Steven, Benjamin, Daniel K, Zimmerman, Kanecia O

“…To provide recommendations for future common data element (CDE) development and collection that increases community partnership, harmonizes data…”
Get full text

SARS-CoV-2 Screening Testing Programs for Safe In-person Learning in K-12 Schools by Kalu, Ibukunoluwa C, Zimmerman, Kanecia O, Goldman, Jennifer L, Keener Mast, Dana, Blakemore, Ashley M, Moorthy, Ganga, Boutzoukas, Angelique E, Campbell, Melissa M, Uthappa, Diya, DeLaRosa, Jesse, Potts, Jessica M, Edwards, Laura J, Selvarangan, Rangaraj, Benjamin, Daniel K, Mann, Tara K, Schuster, Jennifer E

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening testing is a recommended mitigation strategy for schools, although few descriptions of…”
Get full text

Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review by Mann, Tara K, Dail, Robin B, Bailey, Donald E

“…BACKGROUND:Alterations in cognitive/affective functioning are among the most challenging adverse effects experienced by 80% of patients with metastatic…”
Get full text

The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings by MUSSELMAN, Dominique, ROYSTER, Erica B, LAWSON, David H, MILLER, Andrew H, MING WANG, QI LONG, TRIMBLE, Lisa M, MANN, Tara K, GRACIAA, Daniel S, MCNUTT, Marcia D, AUYEUNG, N. S. Freda, OLIVER, Lindsay

“…Interleukin (IL)-2, a T-cell cytokine used to treat malignant melanoma, can induce profound depression. To determine whether pretreatment with the…”
Get full text

Assessing Depressive Symptoms in Patients With Cancer Treated With Interleukin-2 by McClintock, Shawn M, Dail, Robin B, Howe-Martin, Laura S, Mann, Tara K, Bailey, Donald E

“…BackgroundHigh-dose interleukin-2 is a therapy available for individuals with renal cell carcinoma; however, it can produce adverse effects, specifically…”
Get full text

Assessing Depressive Symptoms in Patients With Cancer Treated With Interleukin-2: A Comparison of 2 Measures by McClintock, Shawn M., Dail, Robin B., Howe-Martin, Laura S., Mann, Tara K., Bailey, Donald E.

Get full text